Back to Agenda
S28 : Paradigm Shift in Oncology Drug Development ~ Challenging Dose Optimization with Clinical Pharmacology Approach ~
Session Chair(s)
Naoki Kotani, MSc
Pharmaceutical Science Dept.
Chugai Pharmaceutical Co., Ltd., Japan
Speaker(s)
Saki Takahashi
Chugai Pharmaceutical Co., Ltd., Japan
Pharmaceutical Science Dept.
Emi Kamiyama
Daiichi Sankyo Company, Limited, Japan
Associate Director, Quantitative Clinical Pharmacology Department
Dose Optimization from the Viewpoint of Phase 1 Trialist
Takafumi Koyama
National Cancer Center Hospital, Japan
Head of Physicians, Department of Experimental Therapeutics
Takahiro Ito
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Have an account?